Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. Am J Hematol • November 13, 2019
Clinical Outcomes with Unfractionated Heparin Monitored by Anti-Factor Xa vs. Activated Partial Thromboplastin Time. Am J Hematol • June 28, 2019
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool. Am J Hematol • July 25, 2017
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial. Am J Hematol • June 5, 2014
Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. Am J Hematol • December 25, 2013
White blood cell count and mortality in patients with acute pulmonary embolism. Am J Hematol • September 24, 2013
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes. Am J Hematol • September 24, 2013
Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol • March 23, 2013
Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol • June 12, 2012